Bronchiectasis

Bronchiectasis Symptoms

bronchiectasis symptoms

Primary Bronchiectasis Symptoms

Bronchiectasis can cause a number of symptoms, the most common of which is a chronic, mucus-producing cough. The mucus can be either clear, yellow or green. In some cases, the mucus can be accompanied by blood.

Additional symptoms of bronchiectasis include:

  • Chronic fatigue
  • Shortness of breath
  • Loud wheezing when inhaling
  • Increased sinus discharge
  • Fevers and/or chills
  • Joint pain

While bronchiectasis symptoms are chronic, many people with the condition experience acute episodes in which their symptoms are more frequent or severe than normal (e.g., the presence of three or more symptoms for at least two consecutive days). These episodes are referred to as exacerbations. Sometimes, exacerbations are accompanied by a lung infection, as bronchiectasis makes people more susceptible to the harmful effects of viruses and bacteria.

Cellular therapy is an innovative treatment that has become available to individuals who have been diagnosed with bronchiectasis and other lung diseases. This therapy not only has the potential to help reduce inflammation and alleviate symptoms, but it may also help slow the progression of the disease. This makes it an ideal supplement to other traditional forms of treatment. The Lung Institute offers cellular therapy, which is performed on an outpatient basis over the course of two days. And because the cells used in the procedures are taken from the patient’s own body, these treatments are not associated with any major side effects.

If you’d like to learn more about how cellular therapy might be able to help alleviate your bronchiectasis symptoms, contact the Lung Institute at 888-745-6697. We have a compassionate team standing by to answer your questions.

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months of COPD patients.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.